What is NDC 0781-6014?

0781-6014 is the product NDC for Brinzolamide, Brinzolamide 10 mg/mL suspension/ drops, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Brinzolamide?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Brinzolamide NDC 0781-6014 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-6014Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-6014Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-6014-70	00781601470	1 BOTTLE, PLASTIC in 1 CARTON (0781-6014-70) / 10 mL in 1 BOTTLE, PLASTICMarketed from Mar 8, 2021
0781-6014-85	00781601485	1 BOTTLE, PLASTIC in 1 CARTON (0781-6014-85) / 15 mL in 1 BOTTLE, PLASTICMarketed from Mar 8, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brinzolamide
Generic name (nonproprietary): brinzolamide
Active ingredients: Brinzolamide — 10 mg/mL
Dosage form: Suspension/ drops
Route: Ophthalmic
Labeler: Sandoz IncNDC labeler code 0781
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020816
Marketing start: Mar 8, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)
Identifiers: Product ID 0781-6014_dff324e7-139a-429e-989e-9d1ac7433d75SPL ID dff324e7-139a-429e-989e-9d1ac7433d75SPL set ID ed6dbc25-47d7-42db-9787-5814d71f45ceRxCUI 308805UNII 9451Z89515
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781601470 followed by a unit qualifier and the quantity

Package 00781-6014-70. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2023.

Indications (excerpt from the label)

Brinzolamide ophthalmic suspension 1% is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0781-6014

What is NDC 0781-6014?: 0781-6014 is the product NDC for Brinzolamide, Brinzolamide 10 mg/mL suspension/ drops, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Brinzolamide.
What is the active ingredient?: Brinzolamide.
Who is the labeler?: Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Brinzolamide?: 4 other product NDCs are listed under this name. See all Brinzolamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Brinzolamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Brinzolamide	Brinzolamide 10 mg/mL	Suspension/ dropsOphthalmic	Padagis US LLC	0574-4012	00574-4012-1000574-4012-15
Brinzolamide	Brinzolamide 10 mg/mL	Suspension/ dropsOphthalmic	Bryant Ranch Prepack	72162-2201	72162-2201-0272162-2201-04
Brinzolamide	Brinzolamide 10 mg/mL	Suspension/ dropsOphthalmic	Bausch & Lomb Incorporated	24208-464	24208-0464-1024208-0464-15
Brinzolamide	Brinzolamide 10 mg/mL	Suspension/ dropsOphthalmic	Oceanside Pharmaceuticals.	68682-464	68682-0464-1068682-0464-15

Other NDCs under NDA 020816

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020816
Product	Strength	Form · route	Labeler	Product NDC
Azoptbrinzolamide	Brinzolamide 10 mg/mL	Suspension/ dropsOphthalmic	Sandoz Inc	66758-085